Plasma wakefield accelerators have been used to accelerate electron and positron particle beams with gradients that are orders of magnitude larger than those achieved in conventional accelerators. In addition to being accelerated by the plasma wakefield, the beam particles also experience strong transverse forces that may disrupt the beam quality. Hollow plasma channels have been proposed as a technique for generating accelerating fields without transverse forces. Here we demonstrate a method for creating an extended hollow plasma channel and measure the wakefields created by an ultrarelativistic positron beam as it propagates through the channel. The plasma channel is created by directing a high-intensity laser pulse with a spatially modulated profile into lithium vapour, which results in an annular region of ionization. A peak decelerating field of 230 MeV m−1 is inferred from changes in the beam energy spectrum, in good agreement with theory and particle-in-cell simulations.
Plasma waves generated in the wake of intense, relativistic laser 1,2 or particle beams 3,4 can accelerate electron bunches to giga-electronvolt (GeV) energies in centimetre-scale distances. This allows the realization of compact accelerators having emerging applications, ranging from modern light sources such as the free-electron laser (FEL) to energy frontier lepton colliders. In a plasma wakefield accelerator, such multi-gigavoltper-metre (GV m -1 ) wakefields can accelerate witness electron bunches that are either externally injected 5,6 or captured from the background plasma 7,8 . Here we demonstrate optically triggered injection 9,10,11 and acceleration of electron bunches, generated in a multi-component hydrogen and helium plasma employing a spatially aligned and synchronized laser pulse. This "plasma photocathode" decouples injection from wake excitation by liberating tunnel-ionized helium electrons directly inside the plasma cavity, where these cold electrons are then rapidly boosted to relativistic velocities. The injection regime can be accessed via optical 11 density down-ramp injection 18,19,20 , is highly tunable and paves the way to generation of electron beams with unprecedented low transverse emittance, high current and 6D-brightness 12 . This experimental path opens numerous prospects for transformative plasma wakefield accelerator applications based on ultrahigh brightness beams.The advent of photoinjectors in state-of-the-art linear accelerators (linacs) has enabled the substantial increases in electron beam quality that have ushered in an era of new scientific capabilities, as exemplified by the introduction of the hard X-ray FEL 13 . These photoinjectors produce electron beams in electric fields of ~100 megavolts-per-metre (MV m -1 ). This injection environment largely determines key beam qualities such as the transverse emittance (phase space area) and beam brightness. The strong accelerating field restricts emittance dilution and pulse lengthening by quickly increasing the relativistic Lorentz factor of the beam, γ = (1-v 2 /c 2 ) -1/2 , where v is the electron velocity and c is the speed of light, thus diminishing these effects
This report presents the conceptual design of a new European research infrastructure EuPRAXIA. The concept has been established over the last four years in a unique collaboration of 41 laboratories within a Horizon 2020 design study funded by the European Union. EuPRAXIA is the first European project that develops a dedicated particle accelerator research infrastructure based on novel plasma acceleration concepts and laser technology. It focuses on the development of electron accelerators and underlying technologies, their user communities, and the exploitation of existing accelerator infrastructures in Europe. EuPRAXIA has involved, amongst others, the international laser community and industry to build links and bridges with accelerator science — through realising synergies, identifying disruptive ideas, innovating, and fostering knowledge exchange. The Eu-PRAXIA project aims at the construction of an innovative electron accelerator using laser- and electron-beam-driven plasma wakefield acceleration that offers a significant reduction in size and possible savings in cost over current state-of-the-art radiofrequency-based accelerators. The foreseen electron energy range of one to five gigaelectronvolts (GeV) and its performance goals will enable versatile applications in various domains, e.g. as a compact free-electron laser (FEL), compact sources for medical imaging and positron generation, table-top test beams for particle detectors, as well as deeply penetrating X-ray and gamma-ray sources for material testing. EuPRAXIA is designed to be the required stepping stone to possible future plasma-based facilities, such as linear colliders at the high-energy physics (HEP) energy frontier. Consistent with a high-confidence approach, the project includes measures to retire risk by establishing scaled technology demonstrators. This report includes preliminary models for project implementation, cost and schedule that would allow operation of the full Eu-PRAXIA facility within 8—10 years.
Active plasma lensing is a compact technology for strong focusing of charged particle beams, which has gained considerable interest for use in novel accelerator schemes. While providing kT/m focusing gradients, active plasma lenses can have aberrations caused by a radially nonuniform plasma temperature profile, leading to degradation of the beam quality. We present the first direct measurement of this aberration, consistent with theory, and show that it can be fully suppressed by changing from a light gas species (helium) to a heavier gas species (argon). Based on this result, we demonstrate emittance preservation for an electron beam focused by an argon-filled active plasma lens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.